rs2742327

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001267550.2(TTN):​c.21962-23A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 1,598,260 control chromosomes in the GnomAD database, including 62,956 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.34 ( 11036 hom., cov: 33)
Exomes 𝑓: 0.24 ( 51920 hom. )

Consequence

TTN
NM_001267550.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.850

Publications

16 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but rather VUS (scored 4 / 10). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-178722960-T-C is Benign according to our data. Variant chr2-178722960-T-C is described in ClinVar as Benign. ClinVar VariationId is 671270.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.633 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.21962-23A>G intron_variant Intron 75 of 362 ENST00000589042.5 NP_001254479.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.21962-23A>G intron_variant Intron 75 of 362 5 NM_001267550.2 ENSP00000467141.1

Frequencies

GnomAD3 genomes
AF:
0.343
AC:
52093
AN:
151876
Hom.:
10988
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.552
Gnomad AMI
AF:
0.545
Gnomad AMR
AF:
0.374
Gnomad ASJ
AF:
0.204
Gnomad EAS
AF:
0.652
Gnomad SAS
AF:
0.433
Gnomad FIN
AF:
0.204
Gnomad MID
AF:
0.212
Gnomad NFE
AF:
0.207
Gnomad OTH
AF:
0.316
GnomAD2 exomes
AF:
0.318
AC:
74865
AN:
235794
AF XY:
0.310
show subpopulations
Gnomad AFR exome
AF:
0.558
Gnomad AMR exome
AF:
0.419
Gnomad ASJ exome
AF:
0.200
Gnomad EAS exome
AF:
0.670
Gnomad FIN exome
AF:
0.203
Gnomad NFE exome
AF:
0.203
Gnomad OTH exome
AF:
0.276
GnomAD4 exome
AF:
0.245
AC:
354080
AN:
1446266
Hom.:
51920
Cov.:
35
AF XY:
0.247
AC XY:
177677
AN XY:
718002
show subpopulations
African (AFR)
AF:
0.567
AC:
18419
AN:
32494
American (AMR)
AF:
0.416
AC:
17472
AN:
42002
Ashkenazi Jewish (ASJ)
AF:
0.200
AC:
5091
AN:
25416
East Asian (EAS)
AF:
0.649
AC:
25618
AN:
39486
South Asian (SAS)
AF:
0.418
AC:
34846
AN:
83300
European-Finnish (FIN)
AF:
0.204
AC:
10767
AN:
52826
Middle Eastern (MID)
AF:
0.280
AC:
1587
AN:
5660
European-Non Finnish (NFE)
AF:
0.203
AC:
224103
AN:
1105506
Other (OTH)
AF:
0.272
AC:
16177
AN:
59576
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
14215
28431
42646
56862
71077
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8418
16836
25254
33672
42090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.343
AC:
52202
AN:
151994
Hom.:
11036
Cov.:
33
AF XY:
0.349
AC XY:
25936
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.553
AC:
22917
AN:
41462
American (AMR)
AF:
0.375
AC:
5721
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.204
AC:
706
AN:
3468
East Asian (EAS)
AF:
0.651
AC:
3359
AN:
5156
South Asian (SAS)
AF:
0.432
AC:
2077
AN:
4810
European-Finnish (FIN)
AF:
0.204
AC:
2160
AN:
10584
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.207
AC:
14032
AN:
67938
Other (OTH)
AF:
0.318
AC:
670
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1567
3135
4702
6270
7837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
2462
Bravo
AF:
0.368
Asia WGS
AF:
0.544
AC:
1891
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.5
DANN
Benign
0.55
PhyloP100
-0.85
BranchPoint Hunter
4.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2742327; hg19: chr2-179587687; COSMIC: COSV59864550; COSMIC: COSV59864550; API